These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16613138)

  • 1. Antibiotic resistance and identification of uncommon Gram-negative bacteria isolated from sputum of adult patients with cystic fibrosis.
    Gillow C; Shaw A; Moore JE; Elborn JS; Murphy PG
    Br J Biomed Sci; 2006; 63(1):22-5. PubMed ID: 16613138
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.
    Peltroche-Llacshuanga H; Kentrup H; Haase G
    Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):132-4. PubMed ID: 9629983
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a Gram-negative selective agar (GNSA) for the detection of Gram-negative microflora in sputa in patients with cystic fibrosis.
    Moore JE; Xu J; Millar BC; Courtney J; Elborn JS
    J Appl Microbiol; 2003; 95(1):160-6. PubMed ID: 12807467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients].
    Ferroni A; Sermet-Gaudelus I; Abachin E; Quesnes G; Lenoir G; Berche P; Gaillard JL
    Pathol Biol (Paris); 2003 Sep; 51(7):405-11. PubMed ID: 12948761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of gram staining for evaluation of the quality of cystic fibrosis sputum samples.
    Nair B; Stapp J; Stapp L; Bugni L; Van Dalfsen J; Burns JL
    J Clin Microbiol; 2002 Aug; 40(8):2791-4. PubMed ID: 12149331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis.
    Paixão VA; Barros TF; Mota CM; Moreira TF; Santana MA; Reis JN
    Braz J Infect Dis; 2010; 14(4):406-9. PubMed ID: 20963328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients.
    Khanbabaee G; Akbarizadeh M; Sayyari A; Ashayeri-Panah M; Abdollahgorji F; Sheibani K; Rezaeig N
    Braz J Infect Dis; 2012; 16(2):122-8. PubMed ID: 22552452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achromobacter xylosoxidans isolated from the sputum of a patient with cystic fibrosis mutation I1234V with Pseudomonas aeruginosa.
    Abdul Wahab A; Janahi IA; El-Shafie SS
    Saudi Med J; 2004 Jun; 25(6):810-1. PubMed ID: 15195220
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
    Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
    Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.
    Gramegna A; Millar BC; Blasi F; Elborn JS; Downey DG; Moore JE
    J Glob Antimicrob Resist; 2018 Sep; 14():224-227. PubMed ID: 29559421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gram-negative nonfermenting bacteria in respiratory tract infections].
    Stankiewicz M; Przondo-Hessek A
    Med Dosw Mikrobiol; 1985; 37(1):33-40. PubMed ID: 4010380
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.
    Saiman L; Chen Y; Tabibi S; San Gabriel P; Zhou J; Liu Z; Lai L; Whittier S
    J Clin Microbiol; 2001 Nov; 39(11):3942-5. PubMed ID: 11682511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology of sputum from patients at cystic fibrosis centers in the United States.
    Burns JL; Emerson J; Stapp JR; Yim DL; Krzewinski J; Louden L; Ramsey BW; Clausen CR
    Clin Infect Dis; 1998 Jul; 27(1):158-63. PubMed ID: 9675470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.
    Gilljam H; Malmborg AS; Strandvik B
    Thorax; 1986 Aug; 41(8):641-6. PubMed ID: 3097864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
    Finklea JD; Hollaway R; Lowe K; Lee F; Le J; Jain R
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):75-77. PubMed ID: 29884565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of microorganisms isolated from cystic fibrosis patients in Southern Italy, 2002-2010.
    Montagna MT; Barbuti G; Paglionico F; Lovero G; Iatta R; De Giglio O; Cuna T; Coretti C; Santostasi T; Polizzi A; Manca A; Caggiano G; Bouchara JP
    J Prev Med Hyg; 2011 Dec; 52(4):209-14. PubMed ID: 22442927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging microorganisms in cystic fibrosis.
    Fabbri A; Tacchella A; Manno G; Viscoli C; Palmero C; Gargani GF
    Chemioterapia; 1987 Feb; 6(1):32-7. PubMed ID: 3103930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part II: Recommendations for microbiological diagnosis in cystic fibrosis.
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):898-901. PubMed ID: 23272549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.